Genes, environment and Alzheimer's disease
- Amsterdam : Elsevier/Academic Press, 2016
- xxii, 425 p. : illustrations (chiefly color) ; 24 cm.
Machine generated contents note: 1.Molecular Mechanisms of Learning and Memory / Russell Nicholls From Plato's Wax Tablet to Genes Memory Processes Brain Structures Underlying Memory Processes Cellular Basis of Memory The Role of CREB in Memory Pathways Activating CREB HDACs/HATs Role in Gene Transcription References 2.When Cognitive Decline Becomes Pathology: From Normal Aging to Alzheimer's Disease / David P. Salmon Models of Cognitive Decline in Healthy Aging Distinguishing AD-Associated Cognitive Decline from Normal Aging Distinguishing Preclinical AD from Normal Aging with Event-Related Potentials (ERPs) Memory Deficits in Preclinical AD Asymmetric Cognitive Decline in Preclinical AD Summary and Conclusions 3.Adult Neurogenesis and Cognitive Function: Relevance for Disorders Associated with Human Aging / Robert J. Schloesser Introduction Identification and Characterization of Adult Neurogenesis Contents note continued: Development and Maturation of Adult-Born Neurons Adult Mammalian Hippocampal Circuitry Factors Affecting Adult Neurogenesis Proposed Functions of Adult Neurogenesis Neurogenesis, Hippocampal Dysfunction, and Alzheimer's Disease Methodologies for Studying Adult Neurogenesis Conclusion I.HALLMARKS AND GENETIC FORMS OF AD 4.The Amyloid β Precursor Protein and Cognitive Function in Alzheimer's Disease / Robert A. Marr The APP Gene and Its Homologs The APP Protein, Its Domains, and Its Proteolytic Fragments Intracellular Trafficking and Processing of APP Cholesterol and APP Processing APP-Interacting Proteins: Signal Transduction and Processing Functions of APP Does Aβ Have a Function? APP Knockout Mice APP and AD 5.Molecular Pathways in Alzheimer's Disease and Cognitive Function: New Insights into Pathobiology of Tau / Li Gan Contents note continued: Normal Production and Function of Tau Pathogenic Tau Tau-Mediated Neuronal Deficits Targeting Tau in AD: Therapeutic Implications II.GENETIC AND ENVIRONMENTAL RISK FACTORS 6.Apolipoprotein E and Amyloid-β-Independent Mechanisms in Alzheimer's Disease / Guojun Bu APOE Genotypes and Cognitive Functions in Nondemented Individuals APOE and Cholesterol Metabolism in Synaptic Functions APOE, Brain Glucose Metabolism, and Insulin Signaling APOE, Mitochondria Dysfunction, and Tau Phosphorylation APOE, ApoE Receptors, and Synaptic Functions APOE and Cerebrovascular Functions APOE and Inflammatory Response Summary and Perspectives Acknowledgments 7.Lifestyle and Alzheimer's Disease: The Role of Environmental Factors in Disease Development / Orly Lazarov Epidemiological Studies The Benefits of Cognitive Complexity Following the Onset of Dementia Contents note continued: Physical Activity and Exercise Chemical Exposure and AD Risk Metals Air Pollution and Tobacco Smoke Nutrition and the Microbiome Sleep and Circadian Rhythm Socialization 8.Role of BACE1 in Cognitive Function, from Alzheimer's Disease to Traumatic Brain Injury / Giuseppina Tesco BACE1 9.Traumatic Brain Injury and Rationale for a Neuropsychological Diagnosis of Diffuse Axonal Injury / Douglas H. Smith Common TBI-Related Cognitive Deficits Mechanisms of Cognitive Disturbance Following TBI Diffuse Axonal Injury DAI as a Mechanism of Cognitive Dysfunction Following TBI Neurochemical and Neurometabolic Changes Neurometabolic Changes as a Mechanism of Cognitive Dysfunction Following TBI Focal Injuries Focal Brain Injury as a Mechanism of Cognitive Dysfunction Following TBI Neurodegenerative Processes Contents note continued: Neurodegenerative Processes as a Mechanism of Cognitive Dysfunction Following TBI Conclusions 10.Alzheimer's Disease and the Sleep Wake Cycle / Li-Huei Tsai To Sleep, Perchance to Learn Sleep Disturbances and Cognitive Decline Sleep and Aβ Pathology: A Pathogenic Loop Summary and Closing Remarks 11.Stroke, Cognitive Function, and Alzheimer's Disease / Alyson A. Miller Stroke: An Overview Cognitive Impairment and Dementia: AD, VaD, and VCI The Role of the NVU in AD and VCI VCI After Stroke AD and Stroke Prospects for Treatment and Prevention 12.Cerebral Innate Immunity: A New Conceptual Framework for Alzheimer's Disease / Terrence Town Cerebral Innate Immunity in Alzheimer Pathoetiology An Historical Perspective: Innate Immunity in AD Contents note continued: Aβ Immunotherapy and the Role of Mononuclear Phagocytes in Amyloid Plaque Clearance Novel Strategies for Targeting Peripheral Macrophages Versus Brain-Resident Microglia Targeting Cardinal Anti-inflammatory Cytokines to Restrict Cerebral Amyloidosis Chemokines Recruit Monocytes to Aβ Plaques and Dying Neurons Blocking Inflammatory ILs 12 and 23 Prevents Plaque Buildup in Transgenic Mice PPARγ Agonists Reduce Inflammation While Boosting Microglial Aβ Uptake Inflammasome Activation in AD Beclin 1 Regulates Microglial Phagocytosis and May Be Impaired in AD A New Generation of AD Pharmacotherapeutics Targeting Innate Immunity Concluding Remarks Acknowledgements 13.Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer's Disease / Marcelo G. Bonini Epidemiology T2DM: Clinical Description Mouse Models of Type 2 Diabetes Mechanism and Pathways Contents note continued: Cerebrovascular Complications in T2DM: Implications for AD Development Alzheimer's Disease: When Inflammation and Vascular Dysfunction Get to the Brain References